Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin

[1]  C. Hack,et al.  Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation. , 2007, Molecular immunology.

[2]  M. Maurer,et al.  Mast cells--key effector cells in immune responses. , 2007, Trends in immunology.

[3]  David C. Gondek,et al.  Mast cells are essential intermediaries in regulatory T-cell tolerance , 2006, Nature.

[4]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[5]  S. Usami,et al.  Integrins regulate VE-cadherin and catenins: dependence of this regulation on Src, but not on Ras. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Simon,et al.  Quiescent and activated mouse granulocytes do not express granzyme A and B or perforin: similarities or differences with human polymorphonuclear leukocytes? , 2005, Blood.

[7]  J. Trapani,et al.  Extracellular Matrix Remodeling by Human Granzyme B via Cleavage of Vitronectin, Fibronectin, and Laminin* , 2005, Journal of Biological Chemistry.

[8]  S. Nourshargh,et al.  Transmigration through venular walls: a key regulator of leukocyte phenotype and function. , 2005, Trends in immunology.

[9]  B. McManus,et al.  Granzyme B Induces Endothelial Cell Apoptosis and Contributes to the Development of Transplant Vascular Disease , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  M. Tsai,et al.  Mast cells in the development of adaptive immune responses , 2005, Nature Immunology.

[11]  M. Huber,et al.  SHIP Down-Regulates FcεR1-Induced Degranulation at Supraoptimal IgE or Antigen Levels , 2005, The Journal of Immunology.

[12]  B. McManus,et al.  Granzyme B Induces Smooth Muscle Cell Apoptosis in the Absence of Perforin: Involvement of Extracellular Matrix Degradation , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[13]  A. Anel,et al.  Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis , 2004, The Journal of cell biology.

[14]  J. Marshall.  Mast-cell responses to pathogens , 2004, Nature Reviews Immunology.

[15]  J. Marshall,et al.  Mast cells in innate immunity. , 2004, The Journal of allergy and clinical immunology.

[16]  Elisabetta Dejana,et al.  Endothelial cell–cell junctions: happy together , 2004, Nature Reviews Molecular Cell Biology.

[17]  E. Morii,et al.  Strain-dependent inhibitory effect of mutant mi-MITF on cytotoxic activities of cultured mast cells and natural killer cells of mice , 2004, Laboratory Investigation.

[18]  T. Ley,et al.  Lymphocyte-mediated cytotoxicity. , 2003, Annual review of immunology.

[19]  S. Raja,et al.  Cytotoxic granule-mediated apoptosis: unraveling the complex mechanism. , 2003, Current opinion in immunology.

[20]  B. McManus,et al.  Granzyme B in Atherosclerosis and Transplant Vascular Disease: Association with Cell Death and Atherosclerotic Disease Severity , 2003, Modern Pathology.

[21]  A. Anel,et al.  Granzymes are essential for natural killer cell‐mediated and perf‐facilitated tumor control , 2002, European journal of immunology.

[22]  C. Benoist,et al.  Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis , 2002, Science.

[23]  D. Spillmann,et al.  Structural Requirements and Mechanism for Heparin-induced Activation of a Recombinant Mouse Mast Cell Tryptase, Mouse Mast Cell Protease-6 , 2001, The Journal of Biological Chemistry.

[24]  G. Griffiths,et al.  The immunological synapse of CTL contains a secretory domain and membrane bridges. , 2001, Immunity.

[25]  G. Kroemer,et al.  A Role of the Mitochondrial Apoptosis-Inducing Factor in Granulysin-Induced Apoptosis1 , 2001, The Journal of Immunology.

[26]  D. Vestweber,et al.  The cell polarity protein ASIP/PAR‐3 directly associates with junctional adhesion molecule (JAM) , 2001, The EMBO journal.

[27]  A. Fischer,et al.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis. , 1999, Science.

[28]  Kraan,et al.  The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA) , 1999, Clinical and experimental immunology.

[29]  R. Humphries,et al.  Targeted disruption of SHIP leads to Steel factor‐induced degranulation of mast cells , 1998, The EMBO journal.

[30]  D. Friend,et al.  Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. , 1998, Journal of immunology.

[31]  P. Kubes,et al.  A role for mast cells in the development of adjuvant-induced vasculitis and arthritis. , 1998, The American journal of pathology.

[32]  W. Graninger,et al.  Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis. , 1998, Arthritis and rheumatism.

[33]  T. Yamamoto,et al.  Impaired tyrosine phosphorylation and Ca2+ mobilization, but not degranulation, in lyn-deficient bone marrow-derived mast cells. , 1997, Journal of immunology.

[34]  E. Dejana,et al.  Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. , 1996, Journal of immunology.

[35]  B. Echtenacher,et al.  Critical protective role of mast cells in a model of acute septic peritonitis , 1996, Nature.

[36]  S. Abraham,et al.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.

[37]  H. Bayley,et al.  Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins , 1996, Archives of Microbiology.

[38]  E. Springman,et al.  Processing of procarboxypeptidase A and other zymogens in murine mast cells. , 1994, The Journal of biological chemistry.

[39]  P. Kovanen,et al.  Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. , 1994, Circulation.

[40]  F. Breedveld,et al.  Expression of granzymes A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritis. , 1994, Clinical immunology and immunopathology.

[41]  J. Tschopp,et al.  Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Hudig,et al.  Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes. , 1993, Journal of immunology.

[43]  M. Schwartz,et al.  The extracellular matrix as a cell survival factor. , 1993, Molecular biology of the cell.

[44]  J. Enghild,et al.  An unusual specificity in the activation of neutrophil serine proteinase zymogens. , 1990, Biochemistry.

[45]  K. Austen,et al.  Ontogeny of in vitro-differentiated mouse mast cells. , 1987, Federation proceedings.

[46]  H. Müller-Hermelink,et al.  Cloned cytolytic T-effector cells and their malignant variants produce an extracellular matrix degrading trypsin-like serine proteinase. , 1987, Immunology.

[47]  J. August,et al.  Lysosome-associated membrane proteins: characterization of LAMP-1 of macrophage P388 and mouse embryo 3T3 cultured cells. , 1985, Archives of biochemistry and biophysics.

[48]  K. Austen,et al.  Enzymes of the mast cell granule. , 1980, The Journal of investigative dermatology.

[49]  M. Huber,et al.  SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels. , 2005, Journal of immunology.

[50]  K. Ebnet,et al.  Molecular Analysis and Possible Pleiotropic Function(s) of the T Cell-Specific Serine Proteinase-1 (TSP-1) , 1993 .

[51]  J. Tschopp,et al.  Perforin-mediated target cell lysis by cytolytic T lymphocytes. , 1990, Annual review of immunology.